The Tmem16a chloride channel is required for mucin maturation after secretion from goblet-like cells in the Xenopus tropicalis tadpole skin.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 26 02 2024
accepted: 14 10 2024
medline: 27 10 2024
pubmed: 27 10 2024
entrez: 27 10 2024
Statut: epublish

Résumé

The TMEM16A chloride channel is proposed as a therapeutic target in cystic fibrosis, where activation of this ion channel might restore airway surface hydration and mitigate respiratory symptoms. While TMEM16A is associated with increased mucin production under stimulated or pro-inflammatory conditions, its role in baseline mucin production, secretion and/or maturation is less well understood. Here, we use the Xenopus tadpole skin mucociliary surface as a model of human upper airway epithelium to study Tmem16a function in mucus production. We found that Xenopus tropicalis Tmem16a is present at the apical membrane surface of tadpole skin small secretory cells that express canonical markers of mammalian "goblet cells" such as Foxa1 and spdef. X. tropicalis Tmem16a functions as a voltage-gated, calcium-activated chloride channel when transfected into mammalian cells in culture. Depletion of Tmem16a from the tadpole skin results in dysregulated mucin maturation post-secretion, with secreted mucins having a disrupted molecular size distribution and altered morphology assessed by sucrose gradient centrifugation and electron microscopy, respectively. Our results show that in the Xenopus tadpole skin, Tmem16a is necessary for normal mucus barrier formation and demonstrate the utility of this model system to discover new biology relevant to human mucosal biology in health and disease.

Identifiants

pubmed: 39461969
doi: 10.1038/s41598-024-76482-y
pii: 10.1038/s41598-024-76482-y
doi:

Substances chimiques

Anoctamin-1 0
Mucins 0
Xenopus Proteins 0
Chloride Channels 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25555

Subventions

Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/S001034/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/S001034/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/S001034/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/S001034/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/S001034/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : IAA 403
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W006456/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W006456/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W006456/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W006456/1
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

Zhou-Suckow, Z., Duerr, J., Hagner, M. & Mall, M. A. Airway mucus, inflammation and remodeling: Emerging links in the pathogenesis of chronic lung diseases. Cell. Tissue Res. 367, 537–550 (2017).
pubmed: 28108847 doi: 10.1007/s00441-016-2562-z
Kurbatova, P. et al. Model of mucociliary clearance in cystic fibrosis lungs. J. Theor. Biol. 372, 81–88 (2015).
pubmed: 25746843 doi: 10.1016/j.jtbi.2015.02.023
Morgan, L. E. et al. Disulfide disruption reverses mucus dysfunction in allergic airway disease. Nat. Commun. 12, 249 (2021).
pubmed: 33431872 pmcid: 7801631 doi: 10.1038/s41467-020-20499-0
McShane, A. et al. Mucus Curr. Biol. 31, R938–R945 (2021).
pubmed: 34375594 doi: 10.1016/j.cub.2021.06.093
Rommens, J. M. et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245, 1059–1065 (1989).
pubmed: 2772657 doi: 10.1126/science.2772657
Riordan, J. R. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245, 1066–1073 (1989).
pubmed: 2475911 doi: 10.1126/science.2475911
Kerem, B. S. et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 245, 1073–1080 (1989).
pubmed: 2570460 doi: 10.1126/science.2570460
Boucher, R. C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 261, 5–16 (2007).
pubmed: 17222164 doi: 10.1111/j.1365-2796.2006.01744.x
Ehre, C., Ridley, C. & Thornton, D. J. Cystic fibrosis: An inherited disease affecting mucin-producing organs. Int. J. Biochem. Cell. Biol. 52, 136–145 (2014).
pubmed: 24685676 pmcid: 4449140 doi: 10.1016/j.biocel.2014.03.011
Guss, A. M. et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J. 5, 20 (2011).
pubmed: 20631810 doi: 10.1038/ismej.2010.88
Rudkjøbing, V. B. et al. The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients. FEMS Immunol. Med. Microbiol. 65, 236–244 (2012).
pubmed: 22211589 doi: 10.1111/j.1574-695X.2011.00925.x
Middleton, P. G. & Taylor-Cousar, J. L. Development of elexacaftor – tezacaftor – ivacaftor: Highly effective CFTR modulation for the majority of people with cystic fibrosis. Expert Rev. Respir. Med. 15, 723–735 (2021).
pubmed: 33249928 doi: 10.1080/17476348.2021.1855980
Tewkesbury, D. H., Robey, R. C. & Barry, P. J. Progress in precision medicine in cystic fibrosis: A focus on CFTR modulator therapy. Breathe (Sheff) 17, 210112 (2021).
pubmed: 35035569 doi: 10.1183/20734735.0112-2021
Laselva, O. et al. Small-molecule drugs for cystic fibrosis: Where are we now?. Pulm. Pharmacol. Ther. 72, 102098 (2022).
pubmed: 34793977 doi: 10.1016/j.pupt.2021.102098
Danahay, H. & Gosling, M. TMEM16A: An alternative approach to restoring airway anion secretion in cystic fibrosis?. Int. J. Mol. Sci. 21, 2386 (2020).
pubmed: 32235608 pmcid: 7177896 doi: 10.3390/ijms21072386
Danahay, H. L. et al. TMEM16A potentiation: A novel therapeutic approach for the treatment of cystic fibrosis. Am. J. Respir. Crit. Care Med. 201, 946–954 (2020).
pubmed: 31898911 pmcid: 7159426 doi: 10.1164/rccm.201908-1641OC
Mitri, C., Sharma, H., Corvol, H. & Tabary, O. TMEM16A/ANO1: Current strategies and novel drug approaches for cystic fibrosis. Cells 10, 2867 (2021).
pubmed: 34831090 pmcid: 8616501 doi: 10.3390/cells10112867
Pedemonte, N. & Galietta, L. J. V. Structure and function of tmem16 proteins (anoctamins). Physiol. Rev. 94, 419–459 (2014).
pubmed: 24692353 doi: 10.1152/physrev.00039.2011
Oh, U. & Jung, J. Cellular functions of TMEM16/anoctamin. Pflugers Arch. 468, 443 (2016).
pubmed: 26811235 pmcid: 4751194 doi: 10.1007/s00424-016-1790-0
Agostinelli, E. & Tammaro, P. Polymodal control of TMEM16x channels and scramblases. Int. J. Mol. Sci. 23, 1580 (2022).
pubmed: 35163502 pmcid: 8835819 doi: 10.3390/ijms23031580
Fischer, H., Illek, B., Sachs, L., Finkbeiner, W. E. & Widdicombe, J. H. CFTR and calcium-activated chloride channels in primary cultures of human airway gland cells of serous or mucous phenotype. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L585–L594 (2010).
pubmed: 20675434 pmcid: 2957417 doi: 10.1152/ajplung.00421.2009
Huang, F. et al. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc. Natl. Acad. Sci. USA 109, 16354–16359 (2012).
pubmed: 22988107 pmcid: 3479591 doi: 10.1073/pnas.1214596109
Gorrieri, G. et al. Goblet cell hyperplasia requires high bicarbonate transport to support mucin release. Sci. Rep. 6, 1–15 (2016).
doi: 10.1038/srep36016
Kondo, M. et al. Chloride ion transport and overexpression of TMEM16A in a guinea-pig asthma model. Clin. Exp. Allergy. 47, 795–804 (2017).
pubmed: 28109183 doi: 10.1111/cea.12887
Scudieri, P. et al. Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia. J. Physiol. 590, 6141–6155 (2012).
pubmed: 22988141 pmcid: 3530122 doi: 10.1113/jphysiol.2012.240838
Schroeder, B. C., Cheng, T., Jan, Y. N. & Jan, L. Y. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell. 134, 1019–1029 (2008).
pubmed: 18805094 pmcid: 2651354 doi: 10.1016/j.cell.2008.09.003
Caputo, A. et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 322, 590–594 (2008).
pubmed: 18772398 doi: 10.1126/science.1163518
Yang, Y. D. et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 455, 1210–1215 (2008).
pubmed: 18724360 doi: 10.1038/nature07313
Xiao, Q. et al. Voltage- and calcium-dependent gating of TMEM16A/Ano1 chloride channels are physically coupled by the first intracellular loop. Proc. Natl. Acad. Sci. USA. 108, 8891–8896 (2011).
pubmed: 21555582 pmcid: 3102354 doi: 10.1073/pnas.1102147108
Segura-Covarrubias, G. et al. Voltage-dependent protonation of the calcium pocket enable activation of the calcium-activated chloride channel anoctamin-1 (TMEM16A). Sci. Rep. 10, 6644 (2020).
pubmed: 32313203 pmcid: 7170896 doi: 10.1038/s41598-020-62860-9
Qu, Z. & Hartzell, H. C. Anion permeation in Ca2+-activated Cl – channels. J. Gen. Physiol. 116, 825–844 (2000).
pubmed: 11099350 pmcid: 2231816 doi: 10.1085/jgp.116.6.825
Jung, J. et al. Dynamic modulation of ANO1/TMEM16A HCO3- permeability by Ca2+/calmodulin. Proc. Natl. Acad. Sci. USA 110, 360–365 (2013).
pubmed: 23248295 doi: 10.1073/pnas.1211594110
Sondo, E., Caci, E. & Galietta, L. J. V. The TMEM16A chloride channel as an alternative therapeutic target in cystic fibrosis. Int. J. Biochem. Cell Biol. 52, 73–76 (2014).
pubmed: 24704530 doi: 10.1016/j.biocel.2014.03.022
Benedetto, R., Cabrita, I., Schreiber, R. & Kunzelmann, K. TMEM16A is indispensable for basal mucus secretion in airways and intestine. FASEB J. 33, 4502–4512 (2019).
pubmed: 30586313 doi: 10.1096/fj.201801333RRR
Simões, F. B. et al. TMEM16A chloride channel does not drive mucus production. Life Sci. Alliance. 2, e201900462 (2019).
pubmed: 31732694 pmcid: 6859295 doi: 10.26508/lsa.201900462
Dubaissi, E. A tad of hope in the fight against airway disease. Biochem. Soc. Trans. 48, 2347–2357 (2020).
pubmed: 33079166 pmcid: 7614538 doi: 10.1042/BST20200745
Walentek, P. Xenopus epidermal and endodermal epithelia as models for mucociliary epithelial evolution, disease, and metaplasia. Genesis. 59, e23406 (2021).
pubmed: 33400364 doi: 10.1002/dvg.23406
Dubaissi, E. et al. Functional characterization of the mucus barrier on the Xenopus tropicalis skin surface. Proc. Natl. Acad. Sci. USA. 115, 726–731 (2018).
pubmed: 29311327 pmcid: 5789918 doi: 10.1073/pnas.1713539115
Miledi, R. A calcium-dependent transient outward current in Xenopus laevis oocytes. Proc. R. Soc. Lond. 215, 491–497 (1982).
pubmed: 6127718
Barish, M. E. A transient calcium-dependent chloride current in the immature Xenopus oocyte. J. Physiol. 342, 309–325 (1983).
pubmed: 6313909 pmcid: 1193960 doi: 10.1113/jphysiol.1983.sp014852
Wozniak, K. L., Phelps, W. A., Tembo, M., Lee, M. T. & Carlson, A. E. The TMEM16A channel mediates the fast polyspermy block in Xenopus laevis. J. Gen. Physiol. 150, 1249–1259 (2018).
pubmed: 30012842 pmcid: 6122928 doi: 10.1085/jgp.201812071
Ryu, R. H. et al. Cloning and heterologous expression of new xANO2 from Xenopus laevis. Biochem. Biophys. Res. Commun. 408, 559–565 (2011).
pubmed: 21521635 doi: 10.1016/j.bbrc.2011.04.060
Huanosta-Gutiérrez, A. et al. TMEM16A alternative splicing isoforms in Xenopus tropicalis: distribution and functional properties. Biochem. Biophys. Res. Commun. 446, 1096–1101 (2014).
pubmed: 24661876 doi: 10.1016/j.bbrc.2014.03.057
Bowes, J. B. et al. Xenbase: Gene expression and improved integration. Nucleic Acids Res. 38, D607–D612 (2010).
pubmed: 19884130 doi: 10.1093/nar/gkp953
Briggs, J. A. et al. The dynamics of gene expression in vertebrate embryogenesis at single-cell resolution. Science 360 (2018).
Available at. https://kleintools.hms.harvard.edu/tools/currentDatasetsList_xenopus_v2.html
Weinreb, C., Wolock, S. & Klein, A. M. SPRING: A kinetic interface for visualizing high dimensional single-cell expression data. Bioinformatics 34, 1246–1248 (2018).
pubmed: 29228172 doi: 10.1093/bioinformatics/btx792
Dubaissi, E. et al. A secretory cell type develops alongside multiciliated cells, ionocytes and goblet cells, and provides a protective, antiinfective function in the frog embryonic mucociliary epidermis. Development 141, 1514–1525 (2014).
pubmed: 24598166 pmcid: 3957375 doi: 10.1242/dev.102426
Lee, J. et al. A single-cell, time-resolved profiling of Xenopus mucociliary epithelium reveals nonhierarchical model of development. Sci. Adv. 9, eadd5745 (2023).
pubmed: 37027470 pmcid: 10081853 doi: 10.1126/sciadv.add5745
Billett, F. S. & Gould, R. P. Fine structural changes in the differentiating epidermis of Xenopus laevis embryos. J. Anat. 108, 465 (1971).
pubmed: 5575314 pmcid: 1234183
Okuda, K. et al. Localization of secretory mucins MUC5AC and MUC5B in normal/healthy human airways. Am. J. Respir. Crit. Care Med. 199, 715–727 (2019).
pubmed: 30352166 pmcid: 6423099 doi: 10.1164/rccm.201804-0734OC
Walentek, P. et al. ATP4a is required for development and function of the Xenopus mucociliary epidermis - a potential model to study proton pump inhibitor-associated pneumonia. Dev. Biol. 408, 292–304 (2015).
pubmed: 25848696 pmcid: 4592800 doi: 10.1016/j.ydbio.2015.03.013
Chen, G. et al. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J. Clin. Invest. 119, 2914–2924 (2009).
pubmed: 19759516 pmcid: 2752084
Paranjapye, A., Mutolo, M. J., Ebron, J. S., Leir, S. H. & Harris, A. The FOXA1 transcriptional network coordinates key functions of primary human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 319, L126–L136 (2020).
pubmed: 32432922 pmcid: 7468843 doi: 10.1152/ajplung.00023.2020
Huang, F. et al. Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc. Natl. Acad. Sci. 106, 21413–21418 (2009).
pubmed: 19965375 pmcid: 2781737 doi: 10.1073/pnas.0911935106
Caci, E. et al. Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin. PLoS ONE 10, e0131775 (2015).
pubmed: 26121472 pmcid: 4486680 doi: 10.1371/journal.pone.0131775
Qin, Y. et al. Interleukin-13 stimulates MUC5AC expression via a STAT6-TMEM16A-ERK1/2 pathway in human airway epithelial cells. Int. Immunopharmacol. 40, 106–114 (2016).
pubmed: 27588910 doi: 10.1016/j.intimp.2016.08.033
Duran, C., Qu, Z., Osunkoya, A. O., Cui, Y. & Hartzell, H. C. ANOs 3–7 in the anoctamin/Tmem16 Cl – channel family are intracellular proteins. Am. J. Physiol. Cell. Physiol. 302, C482 (2012).
pubmed: 22075693 doi: 10.1152/ajpcell.00140.2011
Schreiber, R., Ousingsawat, J. & Kunzelmann, K. Targeting of intracellular TMEM16 proteins to the plasma membrane and activation by purinergic signaling. Int. J. Mol. Sci. 21, 1–16 (2020).
doi: 10.3390/ijms21114065
Seo, Y. et al. Ani9, a novel potent small-molecule ANO1 inhibitor with negligible effect on ANO2. PLoS ONE 11, e0155771 (2016).
pubmed: 27219012 pmcid: 4878759 doi: 10.1371/journal.pone.0155771
Scudieri, P., Sondo, E., Caci, E., Ravazzolo, R. & Galietta, L. J. V. TMEM16A-TMEM16B chimaeras to investigate the structure-function relationship of calcium-activated chloride channels. Biochem. J. 452, 443–455 (2013).
pubmed: 23570556 doi: 10.1042/BJ20130348
Bradley, E. et al. Pharmacological characterization of TMEM16A currents. Channels. 8, 308–320 (2014).
pubmed: 24642630 pmcid: 4203732 doi: 10.4161/chan.28065
Seo, Y. et al. Inhibition of ANO1/TMEM16A chloride channel by idebenone and its cytotoxicity to cancer cell lines. PLoS ONE 10, e0133656 (2015).
pubmed: 26196390 pmcid: 4511415 doi: 10.1371/journal.pone.0133656
Liu, Y. et al. Characterization of the effects of Cl – channel modulators on TMEM16A and bestrophin-1 Ca2 + activated Cl – channels. Pflugers Arch. Eur. J. Physiol. 467, 1417–1430 (2015).
doi: 10.1007/s00424-014-1572-5
Miner, K. et al. Drug repurposing: the anthelmintics niclosamide and nitazoxanide are potent TMEM16A antagonists that fully bronchodilate airways. Front. Pharmacol. 10, 51 (2019).
pubmed: 30837866 pmcid: 6382696 doi: 10.3389/fphar.2019.00051
Henckels, K. A., Fong, D. & Phillips, J. E. Development of a QPatch-automated electrophysiology assay for identifying TMEM16A small-molecule inhibitors. Assay. Drug Dev. Technol. 18, 134–147 (2020).
pubmed: 32319819 pmcid: 7268545 doi: 10.1089/adt.2019.962
Danahay, H. et al. Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A. Front. Pharmacol. 14, 1142342 (2023).
pubmed: 36950016 pmcid: 10025480 doi: 10.3389/fphar.2023.1142342
Martin, F. J. et al. Ensembl 2023. Nucleic Acids Res. 51, D933–D941 (2023).
pubmed: 36318249 doi: 10.1093/nar/gkac958
Kesimer, M., Makhov, A. M., Griffith, J. D., Verdugo, P. & Sheehan, J. K. Unpacking a gel-forming mucin: A view of MUC5B organization after granular release. Am. J. Physiol. Lung Cell. Mol. Physiol. 298, 15–22 (2010).
doi: 10.1152/ajplung.00194.2009
Abdullah, L. H. et al. Defective postsecretory maturation of MUC5B mucin in cystic fibrosis airways. JCI Insight. 2, e89752 (2017).
pubmed: 28352653 pmcid: 5358479 doi: 10.1172/jci.insight.89752
Bartoszewski, R., Matalon, S. & Collawn, J. F. Ion channels of the lung and their role in disease pathogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 313, 859–872 (2017).
doi: 10.1152/ajplung.00285.2017
Shi, S. et al. Recent progress in structural studies on TMEM16A channel. Comput. Struct. Biotechnol. J. 18, 714–722 (2020).
pubmed: 32257055 pmcid: 7118279 doi: 10.1016/j.csbj.2020.03.015
Namkung, W., Phuan, P. W. & Verkman, A. S. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J. Biol. Chem. 286, 2365–2374 (2011).
pubmed: 21084298 doi: 10.1074/jbc.M110.175109
Rock, J. R. et al. Transmembrane protein 16A (TMEM16A) is a Ca2+-regulated Cl- secretory channel in mouse airways. J. Biol. Chem. 284, 14875–14880 (2009).
pubmed: 19363029 pmcid: 2685669 doi: 10.1074/jbc.C109.000869
Lin, J. et al. TMEM16A mediates the hypersecretion of mucus induced by Interleukin-13. Exp. Cell. Res. 334, 260–269 (2015).
pubmed: 25770012 doi: 10.1016/j.yexcr.2015.02.026
He, M. et al. Chloride channels regulate differentiation and barrier functions of the mammalian airway. Elife. 9, e53085 (2020).
pubmed: 32286221 pmcid: 7182432 doi: 10.7554/eLife.53085
Gustafsson, J. K. et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J. Exp. Med. 209, 1263–1272 (2012).
pubmed: 22711878 pmcid: 3405509 doi: 10.1084/jem.20120562
Chen, E. Y. T., Yang, N., Quinton, P. M. & Chin, W. C. A new role for bicarbonate in mucus formation. Am. J. Physiol. Lung Cell. Mol. Physiol. 299, L542 (2010).
pubmed: 20693315 pmcid: 2957415 doi: 10.1152/ajplung.00180.2010
Sala-Rabanal, M., Yurtsever, Z., Nichols, C. G. & Brett, T. J. Secreted CLCA1 modulates TMEM16A to activate ca(2+)-dependent chloride currents in human cells. Elife. 4, e05875 (2015).
pubmed: 25781344 pmcid: 4360653 doi: 10.7554/eLife.05875
Nyström, E. E. L. et al. V. Calcium-activated chloride channel regulator 1 (CLCA1) controls mucus expansion in colon by proteolytic activity. EBioMedicine. 33, 134–143 (2018).
pubmed: 29885864 pmcid: 6085540 doi: 10.1016/j.ebiom.2018.05.031
Centeio, R., Ousingsawat, J., Schreiber, R. & Kunzelmann, K. CLCA1 regulates airway mucus production and ion secretion through TMEM16A. Int. J. Mol. Sci. 22 (10), 5133 (2021).
pubmed: 34066250 pmcid: 8151571 doi: 10.3390/ijms22105133
Ousingsawat, J., Kongsuphol, P., Schreiber, R. & Kunzelmann, K. CFTR and TMEM16A are separate but functionally related Cl- channels. Cell. Physiol. Biochem. 28, 715–724 (2011).
pubmed: 22178883 doi: 10.1159/000335765
Benedetto, R. et al. Epithelial chloride transport by CFTR requires TMEM16A. Sci. Rep. 7, 12397 (2017).
pubmed: 28963502 pmcid: 5622110 doi: 10.1038/s41598-017-10910-0
Nieuwkoop, P. D. & Faber, J. Normal Table of Xenopus laevis (Daudin) (North-Holland Publishing Company, 1967).
Kim, S. H., Yamamoto, A., Bouwmeester, T., Agius, E. & Robertis, E. M. The role of paraxial protocadherin in selective adhesion and cell movements of the mesoderm during Xenopus gastrulation. Development. 125, 4681–4690 (1998).
pubmed: 9806917 doi: 10.1242/dev.125.23.4681
Harland, R. M. In situ hybridization: an improved whole-mount method for Xenopus embryos. Methods Cell. Biol. 36, 685–695 (1991).
pubmed: 1811161 doi: 10.1016/S0091-679X(08)60307-6
Lea, R., Bonev, B., Dubaissi, E., Vize, P. D. & Papalopulu, N. Multicolor fluorescent in situ mRNA hybridization (FISH) on whole mounts and sections. Methods Mol. Biol. 917, 431–444 (2012).
pubmed: 22956102 doi: 10.1007/978-1-61779-992-1_24
Gilchrist, M. J. et al. Defining a large set of full-length clones from a Xenopus tropicalis EST project. Dev. Biol. 271, 498–516 (2004).
pubmed: 15223350 doi: 10.1016/j.ydbio.2004.04.023
Dubaissi, E., Panagiotaki, N., Papalopulu, N. & Vize, P. D. Antibody development and use in chromogenic and fluorescent immunostaining. Methods Mol. Biol. 917, 411–429 (2012).
pubmed: 22956101 doi: 10.1007/978-1-61779-992-1_23
Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019
Reyes, J. P. et al. Anion permeation in calcium-activated chloride channels formed by TMEM16A from Xenopus tropicalis. Pflugers Arch. 466, 1769–1777 (2014).
pubmed: 24352628 doi: 10.1007/s00424-013-1415-9
Sheehan, J. K. et al. Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem. J. 347, 37 (2000).
pubmed: 10727399 pmcid: 1220928 doi: 10.1042/bj3470037
Kishimoto, H., Ridley, C. & Thornton, D. J. The lipophilic cyclic peptide cyclosporin A induces aggregation of gel-forming mucins. Sci. Rep. 12, 6153 (2022).
pubmed: 35418571 pmcid: 9008041 doi: 10.1038/s41598-022-10125-y

Auteurs

Eamon Dubaissi (E)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.
Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Emma N Hilton (EN)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.
Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Sarah Lilley (S)

Sussex Drug Discovery Centre, University of Sussex, Falmer, Brighton, BN1 9QJ, UK.

Richard Collins (R)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Charlotte Holt (C)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Peter March (P)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Henry Danahay (H)

Enterprise Therapeutics, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, BN1 9SB, UK.

Martin Gosling (M)

Sussex Drug Discovery Centre, University of Sussex, Falmer, Brighton, BN1 9QJ, UK.
Enterprise Therapeutics, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, BN1 9SB, UK.

Richard K Grencis (RK)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.
Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

Ian S Roberts (IS)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK.
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK.

David J Thornton (DJ)

School of Biological Sciences, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.
Wellcome Centre for Cell Matrix Research, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK. dave.thornton@manchester.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH